← Open Payments lookup

FRANCY SHU: Open Payments

NPI 1437479938 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$11,967 in 119 payments from 32 companies in 2025. Trend: 2023 $25,841 · 2024 $22,983 · 2025 $11,967

Speaker / faculty: $3,920Consulting: $3,563Food & beverage: $2,245Travel & lodging: $2,240
CompanyPaymentsAmount
Grifols USA, LLC10$5,066
Grifols Shared Services North America, Inc.13$5,060
ABBVIE INC.35$445
ARGENX US, INC.5$144
Genentech USA, Inc.4$120
Lundbeck LLC5$103
Teva Pharmaceuticals USA, Inc.4$98
Axsome Therapeutics, Inc.3$86
ACADIA Pharmaceuticals Inc3$84
Merz Pharmaceuticals, LLC3$83

Products named: Gamunex-C, UBRELVY, QULIPTA, VYVGART HYTRULO, Ocrevus Zunovo, AUSTEDO XR, VYEPTI, Symbravo.

Industry payments across CA — which companies pay providers there.